Neurology

Engrail Therapeutics

Clinical-stage company developing innovative, precision-targeted therapeutics to improve the lives of patients with neuropsychiatric and neurodevelopmental disorders.

Red Tree Participation
Co-investor in Series B

Red Tree Board Member

Heath Lukatch, Ph.D.

Total Addressable Market
Red Tree Board Member(s)

Red Tree Board Member

Heath Lukatch, Ph.D.

Red Tree Participation
Co-investor in Series B

Engrail Therapeutics

Neurology
Total Addressable Market
Red Tree Board Member(s)

Red Tree Board Member

Heath Lukatch, Ph.D.

Red Tree Participation
Co-investor in Series B